Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
Autor: | Sukmawan, Renan1, Hoetama, Erick1 erick.hoetama@gmail.com, Danny, Siska Suridanda1, Giantini, Astuti2, Listiyaningsih, Erlin3, Rejeki, Vidya Gilang1, Alkatiri, Amir Aziz1, Firdaus, Isman1 |
---|---|
Zdroj: | Pharmacology Research & Perspectives. Apr2021, Vol. 9 Issue 2, p1-8. 8p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |